Variation in Antithrombotic Therapy and Clinical Outcomes in Patients with Preexisting Atrial Fibrillation Undergoing TAVR: Insights from the STS/ACC TVT Registry(®)

BACKGROUND: Optimal antithrombotic management of patients with pre-existing atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) is challenging given the need to balance the risk of bleeding and thromboembolism. We aimed to examine variation in care and association of an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Circ Cardiovasc Interv
Autori principali: Sherwood, Matthew W., Gupta, Aakriti, Vemulapalli, Sreekanth, Li, Zhuokai, Piccini, Jonathan, Harrison, J. Kevin, Dai, David, Vora, Amit N., Mack, Michael J., Holmes, David R., Rumsfeld, John S., Cohen, David J., Thourani, Vinod H., Kirtane, Ajay J., Peterson, Eric D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300574/
https://ncbi.nlm.nih.gov/pubmed/33877866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009963
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi